WP1
Towards flexible, easily transferable multi-product technologies
•	Modular glycan expression systems for bacterial vaccines
•	Modular antigen display on protein nanoparticles
•	Novel modular VLPs platforms 
WP2
Towards integrated engineering platforms to automate manufacturing
•	Rapid platform for pDNA production
•	Automated microscale processing
•	Integrated microfluidics for mRNA production
•	Scalable GMP microfluidics platform particles production
•	Reducing adenovirus impurities
WP3
Towards simplified regimens, extended shelf life and delivery at reduced waste
•	Systems for microparticles encapsulation
•	Novel spray- and freeze-dried formulations
•	Microneedle array patch development